Journal articleJournal of Biotechnology and Biomedicine
Extraction-Free Testing for SARS-CoV-2 in Nasal Swab and Saliva Samples on a Single High-Throughput Platform
A production-minded paper on extraction-free SARS-CoV-2 testing that consolidates nasal swab and saliva workflows onto a single high-throughput platform, emphasizing assay throughput, specimen flexibility, and practical deployment.
Co-author; startup-era extraction-free testing and workflow implementation context.
Citation
Qiu Y, Lu L, Halven A, Terrio R, Yuldelson S, Dougal N, Galbo F, Lu A, Gao D, Blomquist B, Zevallos JP, Lu S-L, Yao X, Harry BL. Extraction-Free Testing for SARS-CoV-2 in Nasal Swab and Saliva Samples on a Single High-Throughput Platform. Journal of Biotechnology and Biomedicine. 2024;7(2). doi:10.26502/jbb.2642-91280144.
COVIDFast: A high-throughput and RNA extraction-free method for SARS-CoV-2 detection in swab or saliva
The preprint version of the COVIDFast workflow, documenting high-throughput extraction-free SARS-CoV-2 detection from swab and saliva and the practical assay architecture behind rapid clinical-scale deployment.
Qiu Y, Lu L, Halven A, Terrio R, Yuldelson S, Dougal N, Galbo F, Lu A, Gao D, Blomquist B, Zevallos J, Harry BL, Yao X, Lu S-L. COVIDFast: A high-throughput and RNA extraction-free method for SARS-CoV-2 detection in swab (SwabFAST) or saliva (SalivaFAST). medRxiv. 2022. doi:10.1101/2021.12.29.21268527.
Journal articleAmerican Journal of Surgical Pathology
UTROSCT with extensive rhabdoid differentiation, malignant behavior, and ESR1-NCOA2 fusions
A rare-tumor surgical pathology paper describing aggressive UTROSCT cases with extensive rhabdoid differentiation and ESR1-NCOA2 fusions, linking histology with molecular findings in clinically meaningful detail.
Bennett JA, Lastra RR, Barroeta JE, Parilla M, Galbo F, Wanjari P, Young RH, Krausz T, Oliva E. Uterine Tumor Resembling Ovarian Sex Cord Stromal Tumor (UTROSCT): A Series of 3 Cases With Extensive Rhabdoid Differentiation, Malignant Behavior, and ESR1-NCOA2 Fusions. American Journal of Surgical Pathology. 2020;44(11):1563-1572. doi:10.1097/PAS.0000000000001543.
Validation of EDTA Decalcification for Clinical Molecular Next Generation Sequencing Studies
Poster work centered on whether EDTA decalcification can preserve downstream performance for clinical molecular NGS, framed around validation discipline rather than idealized bench conditions.
Validation of EDTA Decalcification for Clinical Molecular Next Generation Sequencing Studies. USCAP poster. 2019.
Journal articleHuman Pathology
Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers
A targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers that grounds genomic findings in disease-specific pathology rather than treating colorectal cancer as a uniform entity.
Co-author; genomics and molecular pathology laboratory contributor.
Citation
Alpert L, Yassan L, Poon R, Kadri S, Niu N, Patil SA, Mujacic I, Montes D, Galbo F, Wurst MN, Zhen CJ, Cohen RD, Rubin DT, Pekow JR, Weber CR, Xiao SY, Hart J, Segal J, Setia N. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers. Human Pathology. 2019;89:44-50. doi:10.1016/j.humpath.2019.04.013.
System for Informatics in the Molecular Pathology Laboratory: An Open-Source End-to-End Solution for Next-Generation Sequencing Clinical Data Management
An end-to-end informatics paper for clinical molecular pathology that centers on open-source data management for NGS workflows, connecting sequencing operations to the practical realities of case handling and clinical reporting.
Kang W, Kadri S, Puranik R, Wurst MN, Patil SA, Mujacic I, Benhamed S, Niu N, Zhen CJ, Ameti B, Long BC, Galbo F, Montes D, Iracheta C, Gamboa VL, Lopez D, Yourshaw M, Lawrence CA, Aisner DL, Fitzpatrick C, McNerney ME, Wang YL, Andrade J, Volchenboum SL, Furtado LV, Ritterhouse LL, Segal JP. System for Informatics in the Molecular Pathology Laboratory: An Open-Source End-to-End Solution for Next-Generation Sequencing Clinical Data Management. Journal of Molecular Diagnostics. 2018;20(4):522-532. doi:10.1016/j.jmoldx.2018.03.008.